These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35282059)

  • 1. Autophagy related long non-coding RNA and breast cancer prognosis analysis and prognostic risk model establishment.
    Luo Z; Nong B; Ma Y; Fang D
    Ann Transl Med; 2022 Jan; 10(2):58. PubMed ID: 35282059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer.
    Chen J; Li X; Yan S; Li J; Zhou Y; Wu M; Ding J; Yang J; Yuan Y; Zhu Y; Wu W
    Front Oncol; 2022; 12():929240. PubMed ID: 36591508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
    Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
    World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new horizon of biomarker in melanoma patients: A study based on autophagy-related long non-coding RNA.
    Li Z; Wei J; Zheng H; Zhang Y; Song M; Cao H; Jin Y
    Medicine (Baltimore); 2022 Jan; 101(1):e28553. PubMed ID: 35029926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J; Liang Y; Gu JJ; Huang Y; Wang B
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel autophagy-related lncRNA prognostic risk model for breast cancer.
    Li X; Jin F; Li Y
    J Cell Mol Med; 2021 Jan; 25(1):4-14. PubMed ID: 33216456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
    Qin M; Ma Y; Wang Z; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
    Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
    Front Genet; 2021; 12():569318. PubMed ID: 33796128
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.
    Wu Q; Li Q; Zhu W; Zhang X; Li H
    J Cell Mol Med; 2021 Apr; 25(8):4088-4098. PubMed ID: 33694315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
    Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
    J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autophagy-related lncRNA prognostic risk model for thyroid cancer.
    Shan Y; He R; Yang X; Zang S; Yao S; Gao M; Li S; Yin Z
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1621-1631. PubMed ID: 34724113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
    Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
    Front Oncol; 2022; 12():988680. PubMed ID: 36203428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
    Wu L; Wen Z; Song Y; Wang L
    J Cell Mol Med; 2021 Jun; 25(12):5681-5690. PubMed ID: 33987935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
    Li X; Li Y; Yu X; Jin F
    J Transl Med; 2020 Aug; 18(1):331. PubMed ID: 32867770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer.
    Tan M; Huang G; Chen J; Yi J; Liu X; Liao N; Hu Y; Zhou W; Guo Q
    Am J Transl Res; 2022; 14(5):2779-2800. PubMed ID: 35702100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
    Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
    Front Oncol; 2020; 10():597569. PubMed ID: 33614483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.